Webinars Archives - Page 8 of 16 - EMEA

This site provides INTERCEPT product information for International audiences .

Safety surveillance and the introduction of pathogen reduced platelets

Safety surveillance and the introduction of pathogen reduced platelets

by jaycornell | May 5, 2025

Dr. John Pitman, PhD Cerus Corporation Concord, USA

Ordering platelet concentrates: does pathogen inactivation matter to the clinician?

Ordering platelet concentrates: does pathogen inactivation matter to the clinician?

by jaycornell | May 5, 2025

Prof. Dr. Helmut Ostermann, LMU Kliniken University of Munich Munich, Germany

Assessment of plasma preparations in TTP

Assessment of plasma preparations in TTP

by jaycornell | May 5, 2025

Prof. Dr. Paul Coppo, MD, CNR-MAT, AP-HP Hóspital Saint-Antoine Paris, France

Assessment of plasma preparations in TTP

Assessment of plasma preparations in TTP

by jaycornell | May 5, 2025

Prof. Dr. Paul Coppo, MD, CNR-MAT, AP-HP Hóspital Saint-Antoine Paris, France

Transfusion transmitted bacterial infections in patients: why are they often undetected and underreported?

Transfusion transmitted bacterial infections in patients: why are they often undetected and underreported?

by jaycornell | May 5, 2025

Dr. Richard J. Benjamin, MBChB, PhD, FRCPath Cerus Corporation Concord, California, USA

« Older Entries

Next Entries »